QMS Medical Allied Services Limited - trading in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L33309MH2017PLC299748 Incorporated 14 September 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: QMSMEDI Public Limited Company trading MSME · Medium
Market Cap
₹329 Cr
QMSMEDI-BE · NSE
Share Price
₹170.01
+0.05% today
Revenue
₹173 Cr
FY 2025-26 · +10.8% YoY
EBITDA
₹26.62 Cr
Margin 15.4%
Net Profit
₹10.07 Cr
FY 2025-26 · -16.6% YoY
P/E (TTM)
33.3x
P/B 3.7x
ROE
12.3%
ROCE 13.9%
Debt / Equity
0.69
Interest cover 29.9x

About QMS Medical Allied Services Limited

Data last updated:

QMS Medical Allied Services Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 14 September 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L33309MH2017PLC299748. Its GSTIN is 27AAACQ4954G1ZB (Maharashtra). The company holds 4 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on NSE: QMSMEDI.

The company has an authorised share capital of ₹23 Cr and a paid-up capital of ₹19.34 Cr. It was formerly known as Qms Medical Allied Services Private Limited. It is led by directors including Mahesh Pahalraj Makhija (Managing Director) and Prajwal Jayasheela Poojari.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹172.88 Cr, a growth of 10.8% compared to the previous year. For the same year it recorded a net profit of ₹10.07 Cr (net margin 5.8%) and EBITDA of ₹26.62 Cr (EBITDA margin 15.4%). The net worth stands at ₹104.2 Cr (up 16.2% YoY). Total assets are valued at ₹189.1 Cr (up 12.8% YoY).

The company has about 83 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Qms Medical Allied Services and Qms Mas. As per MCA filings, the company has open charges of ₹86.2 Cr and satisfied charges of ₹117.66 Cr on record. The company has 4 deals on record (2 secondary share transfers, 1 funding round, 1 ipo), with disclosed funding of ₹3.75 Cr; the latest was in October 2022.

QMS Medical Allied Services Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0013077). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qmsmas.com.

Company details

CIN L33309MH2017PLC299748
Registration Number 299748
Incorporation Date 14 September 2017
ROC Mumbai
Listing Status Listed - Listed on NSE (QMSMEDI)
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0013077

CIN history

QMS Medical Allied Services has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L33309MH2017PLC299748, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L33309MH2017PLC299748Current
U33309MH2017PLC299748Previous
U33309MH2017PTC299748Previous

Recognitions & Rankings of QMS Medical Allied Services

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-18-0013077

Contact details

QMS Medical Allied Services Limited's registered office is in Mumbai, Maharashtra.

  • Social Media
  • Registered Address
    A1 A2/B1 B2 Navkala Bharti Bldg Plot No16 Prabhat Colony Opp Near Santacruz Bus Depot Sant, Acruz East, Mumbai, Maharashtra, India – 400055
  • Industry
    Trading, Wholesale, Other Wholesale
Comprehensive company report
QMS Medical Allied Services Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

QMS Medical Allied Services operates two associated brands: QMS MEDICAL ALLIED SERVICES and QMS MAS. Each brand links to its own profile.

BrandDescriptionWebsite
Online store for medical devices, instruments, and supplies in India.qmsmeds.com
Provider of digital marketing & scientific solution services for medical devices manufacturersqmsmas.com

Business activity

The main business activities of QMS Medical Allied Services are trade and hospital and medical care. In detail, this covers wholesale trading and other hospital and medical care activities. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of QMS Medical Allied Services Limited, buy the company report.

Financials of QMS Medical Allied Services Limited

FY 2025-26 filings available

QMS Medical Allied Services Limited reported revenue of ₹172.88 Cr (up 10.8% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹173 Cr
+10.8% YoY
EBITDA
₹26.62 Cr
+4.8% YoY
Profit After Tax
₹10.07 Cr
-16.6% YoY
Net Worth
₹104 Cr
+16.2% YoY
Total Assets
₹189 Cr
+12.8% YoY
Total Debt
₹74.48 Cr
+23.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24
Income statement
Revenue173156122
Revenue growth+10.8%+27.7%-
EBITDA26.6225.4018.34
EBITDA margin+15.4%+16.3%+15.0%
Profit before tax16.3818.6512.23
Net profit10.0712.079.00
Net profit margin+5.8%+7.7%+7.4%
EPS (₹)6.326.775.04
Balance sheet
Total assets189168113
Net worth10489.7178.51
Total debt74.4860.2834.54
Cash & bank1.201.070.31
Net working capital11394.5281.88
Cash flow
Cash from operations19.4419.171.36
Cash from investing(20.42)(45.49)(2.73)
Cash from financing1.1126.840.41
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue52.5256.8744.4237.2644.7046.5044.5843.87
Revenue growth (YoY)+17.5%+22.3%-0.4%-15.1%+20.2%+53.1%--
Other income0.220.420.220.300.220.321.090.19
EBITDA6.528.315.916.756.926.546.376.95
EBITDA margin+12.4%+14.6%+13.3%+18.1%+15.5%+14.1%+14.3%+15.8%
Depreciation1.601.471.391.020.940.931.360.86
Interest1.861.712.081.751.361.441.411.31
Profit before tax3.285.552.664.284.844.494.694.97
Tax0.841.590.781.101.271.331.091.50
Net profit2.443.961.883.183.573.163.603.47
EPS (₹)1.262.050.971.241.712.201.871.63
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue15214512210414612272.74
Revenue growth+5.1%+18.6%+17.4%-28.9%+19.9%+67.8%-
EBITDA21.0823.3318.3411.3316.6416.999.60
EBITDA margin+13.8%+16.1%+15.0%+10.9%+11.4%+13.9%+13.2%
Profit before tax9.3114.4312.238.7114.4614.908.72
Net profit6.5910.429.006.389.6910.916.32
Net profit margin+4.3%+7.2%+7.4%+6.1%+6.6%+8.9%+8.7%
EPS (₹)3.515.845.043.5728.4029.0221.00
Balance sheet
Total assets19616611396.0163.0139.9321.01
Net worth10488.0478.5170.4031.0320.329.41
Total debt90.9277.252.3725.5231.9719.6011.60
Cash & bank0.110.390.312.372.161.380.66
Net working capital10388.0881.8865.6054.8529.4017.58
Cash flow
Cash from operations18.7726.091.36(7.54)(1.72)1.884.18
Cash from investing(18.27)(48.90)(1.78)(25.10)2.37(7.84)(3.66)
Cash from financing(0.78)22.88(1.07)31.740.136.690.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue50.9452.3439.1929.5441.2542.3242.3839.38
Revenue growth (YoY)+23.5%+23.7%-7.5%-25.0%+26.0%+39.4%--
Other income0.080.250.070.130.000.150.130.12
Total expenses44.6545.3434.8125.7735.1235.9934.5634.05
EBITDA6.297.004.383.776.136.337.825.33
EBITDA margin+12.3%+13.4%+11.2%+12.8%+14.9%+15.0%+18.5%+13.5%
Depreciation1.431.311.220.920.830.830.900.91
Interest2.212.052.382.061.731.772.731.31
Profit before tax2.733.890.850.923.573.884.323.23
Tax0.691.220.240.340.931.201.260.89

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 18 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue52.5256.8744.4237.2644.7046.5044.5843.87
Revenue growth (YoY)+17.5%+22.3%-0.4%-15.1%+20.2%+53.1%--
Other income0.220.420.220.300.220.321.090.19
EBITDA6.528.315.916.756.926.546.376.95
EBITDA margin+12.4%+14.6%+13.3%+18.1%+15.5%+14.1%+14.3%+15.8%
Depreciation1.601.471.391.020.940.931.360.86
Interest1.861.712.081.751.361.441.411.31
Profit before tax3.285.552.664.284.844.494.694.97
Tax0.841.590.781.101.271.331.091.50
Net profit2.443.961.883.183.573.163.603.47
EPS (₹)1.262.050.971.241.712.201.871.63
ParticularsFY 2025-26FY 2024-25FY 2023-24
Revenue173156122
Revenue growth+10.8%+27.7%-
Other income1.061.720.46
Total expenses146131104
Employee cost0.007.543.67
EBITDA26.6225.4018.34
EBITDA margin+15.4%+16.3%+15.0%
Depreciation4.613.833.44
Interest6.694.643.13
Profit before tax16.3818.6512.23
Tax4.514.963.23
Net profit10.0712.079.00
Net profit margin+5.8%+7.7%+7.4%
EPS (₹)6.326.775.04
ParticularsFY 2025-26FY 2024-25FY 2023-24
Equity & liabilities
Share capital19.3417.8517.85
Reserves & surplus84.8671.8660.66
Shareholders' funds (net worth)10489.7178.51
Minority interest9.7717.390.00
Secured loans69.0154.8233.46
Unsecured loans5.475.461.08
Total debt74.4860.2834.54
Total liabilities189168113
Assets
Gross block72.2566.2130.03
Net block54.6252.4223.58
Capital work in progress2.833.192.06
Investments5.463.232.11
Inventories45.9239.3337.58
Sundry debtors67.3257.9341.39
Cash & bank balances1.201.070.31
Loans & advances22.1218.4824.39
Total current assets137117104
Total current liabilities23.7522.2921.79
Net working capital11394.5281.88
Total assets189168113
ParticularsFY 2025-26FY 2024-25FY 2023-24
Opening cash1.060.311.27
Net cash from operating activities19.4419.171.36
Net cash from investing activities(20.42)(45.49)(2.73)
Net cash from financing activities1.1126.840.41
Net change in cash0.130.52(0.96)
Closing cash1.201.070.31
ParticularsFY 2025-26FY 2024-25FY 2023-24
Growth
Sales growth+10.8%+27.7%-
EBITDA growth+4.8%+38.5%-
PBT growth-11.9%+52.6%+9997.0%
Net income growth-16.6%+34.1%-
Profitability & leverage
Net income margin+6.9%+8.8%+7.4%
Return on capital employed+14.0%+17.7%+13.6%
Return on net worth+12.3%+16.3%+11.5%
Debt / equity0.690.560.44
Long-term debt / equity0.080.070.03
Interest cover29.8521.5021.01
Efficiency & per share
Fixed asset turnover2.503.244.07
Inventory turnover4.064.063.25
Debtors turnover2.763.142.95
EPS (₹)5.246.775.04
Dividend per share (₹)0.500.500.00
Book value per share (₹)53.8850.2643.99
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue50.9452.3439.1929.5441.2542.3242.3839.38
Revenue growth (YoY)+23.5%+23.7%-7.5%-25.0%+26.0%+39.4%--
Other income0.080.250.070.130.000.150.130.12
Total expenses44.6545.3434.8125.7735.1235.9934.5634.05
EBITDA6.297.004.383.776.136.337.825.33
EBITDA margin+12.3%+13.4%+11.2%+12.8%+14.9%+15.0%+18.5%+13.5%
Depreciation1.431.311.220.920.830.830.900.91
Interest2.212.052.382.061.731.772.731.31
Profit before tax2.733.890.850.923.573.884.323.23
Tax0.691.220.240.340.931.201.260.89
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue15214512210414612272.74
Revenue growth+5.1%+18.6%+17.4%-28.9%+19.9%+67.8%-
Other income0.360.460.460.741.420.060.04
Total expenses13112210492.7113010563.14
Employee cost0.006.003.672.613.831.560.92
EBITDA21.0823.3318.3411.3316.6416.999.60
EBITDA margin+13.8%+16.1%+15.0%+10.9%+11.4%+13.9%+13.2%
Depreciation4.123.403.441.071.160.740.36
Interest8.015.963.132.292.441.410.56
Profit before tax9.3114.4312.238.7114.4614.908.72
Tax2.724.003.232.333.773.992.40
Net profit6.5910.429.006.389.6910.916.32
Net profit margin+4.3%+7.2%+7.4%+6.1%+6.6%+8.9%+8.7%
EPS (₹)3.515.845.043.5728.4029.0221.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital19.3417.8517.8517.853.763.763.01
Reserves & surplus84.8870.1960.6652.5527.2716.566.40
Shareholders' funds (net worth)10488.0478.5170.4031.0320.329.41
Secured loans85.4571.790.0025.5231.3818.058.99
Unsecured loans5.475.462.370.000.591.552.61
Total debt90.9277.252.3725.5231.9719.6011.60
Total liabilities19616611396.0163.0139.9321.01
Assets
Gross block37.9032.0730.0328.379.9111.303.63
Net block24.6522.3323.5825.367.9710.173.24
Capital work in progress2.642.932.061.150.000.000.00
Investments63.0948.332.110.000.000.000.00
Inventories45.9239.2837.5829.9324.2520.3115.69
Sundry debtors59.1753.8241.3939.0442.0422.9811.21
Cash & bank balances0.110.390.312.372.161.380.66
Loans & advances22.1917.9924.3915.595.625.122.49
Total current assets12711110486.9374.0749.7930.05
Total current liabilities24.2423.4021.7921.3319.2220.3912.47
Net working capital10388.0881.8865.6054.8529.4017.58
Total assets19616611396.0163.0139.9321.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.380.311.272.161.380.660.14
Net cash from operating activities18.7726.091.36(7.54)(1.72)1.884.18
Net cash from investing activities(18.27)(48.90)(1.78)(25.10)2.37(7.84)(3.66)
Net cash from financing activities(0.78)22.88(1.07)31.740.136.690.00
Net change in cash(0.28)0.07(1.48)(0.90)0.780.730.52
Closing cash0.110.390.312.372.161.380.66
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+5.1%+18.6%+17.4%-28.9%+19.9%+67.8%-
EBITDA growth-9.6%+27.2%+61.9%-31.9%-2.1%+77.0%-
PBT growth-34.5%+17.9%+40.4%-39.8%-3.0%+70.9%+99.1%
Net income growth-36.8%+15.8%+41.1%-34.2%-11.2%+72.6%-
Revenue CAGR (3Y)+13.5%-0.3%+0.0%+12.7%+41.3%+1051.1%-
EBITDA CAGR (3Y)+21.9%+11.9%+2.6%+5.7%+52.9%+1093.3%-
Profitability & leverage
Net income margin+4.4%+7.2%+7.4%+6.1%+7.3%+8.9%+8.7%
Return on capital employed+9.6%+14.6%+14.7%+13.8%+32.8%+53.6%+64.8%
Return on net worth+7.0%+12.5%+12.1%+12.6%+41.6%+73.5%+101.2%
Debt / equity0.870.480.190.571.001.051.29
Long-term debt / equity0.260.170.030.030.040.000.00
Interest cover46.4429.9221.0122.3215.768.686.06
Efficiency & per share
Fixed asset turnover4.354.674.185.4413.8016.3538.49
Inventory turnover3.583.773.623.846.576.785.90
Debtors turnover2.703.043.042.574.507.147.57
EPS (₹)3.465.845.043.5728.4029.0221.00
Dividend per share (₹)0.500.500.500.000.000.000.00
Book value per share (₹)53.8949.3243.9939.4482.4854.0231.25

To see the full year-wise statements and ratios of QMS Medical Allied Services Limited, buy the company report.

Board of directors of QMS Medical Allied Services Limited

QMS Medical Allied Services has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Prajwal Jayasheela PoojariDirector15 Jun 20224 Years 5 MonthsCurrent
Niken Ravin ShahDirector11 Mar 20224 Years 8 MonthsCurrent
Mahesh Pahalraj MakhijaManaging Director14 Sep 20179 Years 2 MonthsCurrent
Sarita Vijay MahajanDirector19 Nov 20241 Years 11 MonthsCurrent
Deena Nath PathakDirector23 Aug 20242 Years 2 MonthsCurrent
Pranav Manhar BadhekaDirector03 Sep 20260 Years 2 MonthsCurrent

Charges & borrowings

Open charges
₹86.2 Cr
Satisfied charges
₹117.66 Cr
Breakdown by lending institutions
Citi Bank N.A.₹76.20 Cr
Others₹10.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Dec 2024101043012Others₹10 CrOpen
11 Oct 2024100988892Citi Bank N.A.₹1.2 CrOpen
31 May 2018100228986Citi Bank N.A.₹75 CrOpen
22 Dec 2025101214246Others₹10 CrSatisfied
09 Nov 2024101011537Others₹20 CrSatisfied

To see the full charge records of QMS Medical Allied Services Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

QMS Medical Allied Services Limited has 4 deals on record (2 secondary share transfers, 1 funding round, 1 ipo), with disclosed funding of ₹3.75 Cr; the latest was in October 2022.

Total deals
4
Secondary share transfers
2
Funding round
1
IPO
1
Disclosed funding
₹3.75 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Oct 2022Secondary share transferUndisclosedBuyer: Others - Qms Medical Allied Services Limited, Elara Capital
Seller: Rikhav Securities Limited , IPO - Qms Medical Allied Services Limited
Oct 2022IPO₹56.87 CrInvestors: IPO - Qms Medical Allied Services Limited, Rikhav Securities Limited , Sky Wanderers LLP
Seller: an individual
Oct 2020Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 2 individuals
Nov 2019Funding round₹3.75 CrInvestors: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for QMS Medical Allied Services Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

QMS Medical Allied Services has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACQ4954G1ZBMaharashtraActive06 Dec 2017
29AAACQ4954G1Z7KarnatakaActive15 Apr 2024
09AAACQ4954G1Z9Uttar PradeshActive18 May 2024

To see the full GST registrations and return filing status of QMS Medical Allied Services Limited, buy the company report.

Recent activity

QMS Medical Allied Services Limited has 16 board changes on record since 2017: 6 appointments and 10 cessations. The latest: Pranav Manhar Badheka was appointed as Director on 03 Sep 2026.

Appointed
Pranav Manhar Badheka was appointed as Director.
Charges
A charge registered on 22 Dec 2025 via Charge ID 101214246 with Others was fully satisfied on 21 Aug 2026.
Charges
A charge with Citi Bank N.A. of Rs. 1.20 Cr registered on 11 Oct 2024 with Charge ID 100988892 was modified on 27 Jul 2026.
Charges
A charge with Citi Bank N.A. of Rs. 75.00 Cr registered on 31 May 2018 with Charge ID 100228986 was modified on 27 Jul 2026.
Filing
Qms Medical Allied Services Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge with Others of Rs. 10.00 Cr registered on 22 Dec 2025 with Charge ID 101214246 was modified on 24 Feb 2026.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101214246 was registered on 22 Dec 2025.
AGM
Qms Medical Allied Services Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge registered on 09 Nov 2024 via Charge ID 101011537 with Others was fully satisfied on 05 Sep 2025.
Ceased
Sarita Vijay Mahajan ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101043012 was registered on 23 Dec 2024.
Appointed
Sarita Vijay Mahajan was appointed as Director.

25 earlier events are in the company report.

Frequently asked questions

QMS Medical Allied Services is an active public limited company based in Mumbai, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 14 September 2017 (9+ years old) and is registered under CIN L33309MH2017PLC299748. Listed on NSE: QMSMEDI.

QMS Medical Allied Services reported revenue of ₹172.88 Cr for FY 2025-26 (up 10.8% YoY) based on consolidated financials.

QMS Medical Allied Services has 6 current directors:

The latest financial statements of QMS Medical Allied Services on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of QMS Medical Allied Services is 27AAACQ4954G1ZB, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 29AAACQ4954G1Z7 (Karnataka), 09AAACQ4954G1Z9 (Uttar Pradesh).

The CIN (Corporate Identification Number) of QMS Medical Allied Services is L33309MH2017PLC299748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. QMS Medical Allied Services is a listed company as per MCA records. Its shares are listed on NSE (symbol: QMSMEDI).

QMS Medical Allied Services was incorporated on 14 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

QMS Medical Allied Services has 4 deals on record (2 secondary share transfers, 1 funding round, 1 ipo), with disclosed funding of ₹3.75 Cr; the latest was in October 2022.

Pranav Manhar Badheka was appointed as Director on 03 Sep 2026. Sarita Vijay Mahajan ceased to be Additional Director on 29 Jan 2025. Sarita Vijay Mahajan was appointed as Director on 19 Nov 2024. QMS Medical Allied Services has 16 board changes on record in total.